[1]
“Comparison of Alendronate and Pamidronate on Bone Loss in Kidney Transplant Patients for the First 6 Months of Transplantation”, IJKD, vol. 5, no. 6, pp. 420–424, Nov. 2011, Accessed: Oct. 26, 2024. [Online]. Available: https://ijkd.org/index.php/ijkd/article/view/492